Congenital hypothyroidism

Archives of Disease in Childhood

Volumn 90, Issue 2, 2005, Pages 112-113

  Lazarus, J H ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; LEVOTHYROXINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BONE AGE; BRAIN DEVELOPMENT; CHILD BEHAVIOR; CHILD DEVELOPMENT; CONGENITAL HYPOTHYROIDISM; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG MEGADOSE; EARLY DIAGNOSIS; HORMONE ACTION; HUMAN; INTELLIGENCE QUOTIENT; LANGUAGE DISABILITY; MENTAL DEFICIENCY; MOTOR DYSFUNCTION; NEWBORN SCREENING; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; SKULL DEVELOPMENT; THYROID HORMONE BLOOD LEVEL; THYROXINE BLOOD LEVEL;

BRAIN; CHILD; COGNITION DISORDERS; CONGENITAL HYPOTHYROIDISM; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYPOTHYROIDISM; INFANT, NEWBORN; INTELLIGENCE; THYROXINE;

EID: 13244290022     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2004.061572     Document Type: Review

References (26)

1. Pass K. Overview of newborn screening for congenital hypothyroidism. In: Hauser P, Rovet J, eds. Thyroid diseases of infancy and childhood. Washington, DC: American Psychiatric Press, 1999:59-84.
2. New England Congenital Hypothyroidism Collaborative. Effects of neonatal screening for hypothyroidism: prevention of mental retardation by treatment before clinical manifestations. Lancet 1981;2:1095-8.
3. Rovet J. Behavioral and cognitive abnormalities associated with congenital hypothyroidism. In: Hauser P, Rovet J, eds. Thyroid diseases of infancy and childhood. Washington, DC: American Psychiatric Press, 1999:85-120.
4. Aronson R, Ehrlich RM, Bailiey JD, et al. Growth in children with congenital hypothyroidism detected by neonatal screening. J Pediatr 1990;116:33-7.
5. Salerno M, Micillo M, Di Maio S, et al. Longitudinal growth, sexual maturation and final height in patients with congenital hypothyroidism detected by neonatal screening. Eur J Endocrinol 2001;145:377-83.
6. Fish LH, Schwartz HL, Cavanaugh J, et al. Replacement dose, metabolism and biovavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N Engl J Med 1987;316:764-70.
7. Americal Academy of Pediatrics, Section on Endocrinology and Committee on Genetics Newborn screening for congenital hypothyroidism: recommended guidelines. Pediatrics 1993;91:1203-9.
8. Rovet JF. In search of the optimal therapy for congenital hypothyroidism. J Pediatr 2004;144:098-700.
9. Bongers-Schokking JJ, Koot HM, Wiersma D, et al. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr 2000;136:292-7.
10. Dubuis JM, Gloriueux J, Richer F, et al. Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose of levothyroxine treatment. J Clin Endocrinol Metab 1996;81:222-7.
11. Rovet JF, Ehrlich RM. Long-term effects of L-thyroxine therapy for congenital hypothyroidism. J Pediatr 1995;126:380-6.
12. Davenport JW, Gonzalez LM. Neonatal thyroxine stimulation in rats: accelerated behavioral maturation and subsequent learning deficit. J Comp Physiol 1973;54:397-408.
13. Stane JM, Greenough WT. Excess neonatal thyroxine effects on learning in infant adolescent rats. Dev Psychobiol 1975;8:469-88.
14. Ng SM, Wong SC, Didi M. Head circumference and linear growth during the first 3 years in treated congenital hypothyroidism in relation to aetiology and initial biochemical severity. Clin Endocrinol 2004;61:155-9.
15. Kreisner E, Schermann L, Camargo-Neto E, et al. Predictors of intellectual outcome in a cohort of Brazilian children with congenital hypothyroidism. Clin Endocrinol 2004;60:250-5.
16. Gauchard GC, Deviterne D, Leheup B, et al. Effect of age at thyroid stimulating hormone normalization on postural control in children with congenital hypothyroidism. Dev Med Child Neurol 2004;46:107-13.
17. Orbeck B, Sundet K, Kase BF, et al. Congenital hypothyroidism: influence of disease severity and L-thyroxine treatment on intellectual, motor, and school-associated outcomes in young adults. Pediatrics 2003;112:923-30.
18. Heyerdahl S, Oerbeck B. Congenital hypothyroidism: developmental outcome in relation to levothyroxine treatment variables. Thyroid 2003;13:1029-38.
19. Alvarez Gonzalez MA, Carvajal Martinez F, Perez Gesen C, et al. Prognosis of cognition in congenital hypothyroidism following early treatment. Double effect hypothesis. Rev Neurol 2004;38:513-17.
20. Simoneau-Roy J, Marti S, Deal C, et al. Cognition and behavior at school entry in children with congenital hypothyroidism treated early with high-dose levothyroxine. J Pediatr 2004;144:698-700.
21. Oerbeck B, Sundet KS, Kase BF, et al. Congenital hypothyroidism: no adverse effects of high dose thyroxine treatment on adult memory, attention, and behaviour. Arch Dis Child 2005;90:132-7.
22. Kohrle J. The deiodinase family: selenoenzymes regulating thyroid hormone availability and action. Cell Mol Life Sci 2000;57:1853-63.
23. Lavado-Autric R, Auso E, Garcia-Velasco JV, et al. Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. J Clin Invest 2003;111:1073-82.
24. Kester MH, Martinez de Mena R, Obregon MJ, et al. Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas. J Clin Endocrinol Metab 2004;89:3117-28.
25. Anderson GW, Schoonover CM, Jones SA. Control of thyroid hormone action in the developing rat brain. Thyroid 2003;13:1039-56.
26. Pearce EN, Bazrafshan HR, He X, et al. Dietary iodine in pregnant women from the Boston, Massachusetts area. Thyroid 2004;14:327-8.